Toward precision medicine in adhd

HIGHLIGHTS

• who: Jan Buitelaar from the Technion Institute of The of, Australia have published the paper: Toward Precision Medicine in ADHD, in the Journal: (JOURNAL)
• future: Work in this direction including out of sample validation is needed. As classical study designs are poor at addressing ADHD heterogeneity future clinical studies using novel designs e_g stepped-care designs are also required as to complement to the more standard efficacy RCTs (Lenze et_al 2020). Because prior studies of these biomarkers have focused on group effects rather than on diagnostic accuracy and individual prediction more work is needed to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.